Mayne Pharma Group (ASX:MYX) Other Operating Expense : A$150.4 Mil (TTM As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Mayne Pharma Group Other Operating Expense?

Mayne Pharma Group's Other Operating Expense for the six months ended in Dec. 2024 was A$35.2 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$150.4 Mil.

Mayne Pharma Group's quarterly Other Operating Expense increased from Dec. 2023 (A$35.9 Mil) to Jun. 2024 (A$115.3 Mil) but then declined from Jun. 2024 (A$115.3 Mil) to Dec. 2024 (A$35.2 Mil).

Mayne Pharma Group's annual Other Operating Expense declined from Jun. 2022 (A$81.1 Mil) to Jun. 2023 (A$73.2 Mil) but then increased from Jun. 2023 (A$73.2 Mil) to Jun. 2024 (A$151.1 Mil).

Mayne Pharma Group Other Operating Expense Historical Data

The historical data trend for Mayne Pharma Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Other Operating Expense Chart

Mayne Pharma Group Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Operating Expense

Get a 7-Day Free Trial

84.56

68.19

81.08

73.24

151.13

Mayne Pharma Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Operating Expense	Get a 7-Day Free Trial															29.17	44.07	35.88	115.25	35.18

Mayne Pharma Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$150.4 Mil.

Mayne Pharma Group Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Mayne Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (ASX:MYX) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

MAYNF:USA HG6:Germany

Address

1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106

Website

http://www.maynepharma.com

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.